RET mutations are associated with a more aggressive phenotype, characterized by a higher lymph node involvement risk, increased distant metastasis likelihood, and a poorer overall prognosis compared to MTC cases with other mutations [81]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.